Clinical Ophthalmic Oncology -

Clinical Ophthalmic Oncology

Retinoblastoma
Buch | Hardcover
XIV, 303 Seiten
2019 | 3rd ed. 2019
Springer International Publishing (Verlag)
978-3-030-11122-9 (ISBN)
128,39 inkl. MwSt
Zu diesem Artikel existiert eine Nachauflage

Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations. 

Clinical Ophthalmic Oncology's clinically focused and user-friendly format allows for rapid retrieval of information in daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehension of procedures and techniques. This volume describes the classification, differential diagnosis, and imaging of retinoblastoma and discusses the most suitable treatment options for different tumor types.


   

Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children's Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology. Jonathan Kim, MD, is Director of the Retinoblastoma Program, Attending Physician, and Associate Professor of Clinical Surgery at the Keck School of Medicine of USC. Dr. Kim provides clinical expertise in the management of pediatric intraocular tumors. He was trained at Memorial Sloan-Kettering Cancer Center, Jules Stein Eye Institute at UCLA, and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. He is developing new treatment modalities to save the eyes of children with retinoblastoma and is actively engaged in new research projects. Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author. Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology. Jesse L. Berry, MD Assistant Professor of Clinical Ophthalmology USC Roski Eye Institute Children's Hospital Los Angeles Keck School of Medicine of USC 1975 Zonal Ave, Los Angeles

Retinoblastoma: Evaluation and Diagnosis.- Differential Diagnosis of Leukocoria.- Retinoblastoma: Staging and Grouping.- Retinoblastoma: Incidence and Etiologic Factors.- Retinoblastoma: An International Perspective.- Retinoblastoma Tumorigenesis.- Animal Models in Retinoblastoma Research.- Retinocytoma or Retinoma.- Retinoblastoma: Genetic Counseling and Testing.- Retinoblastoma: Treatment Options.- Retinoblastoma: Focal Therapy - Laser Treatment and Cryotherapy.- Retinoblastoma: Focal Therapies: Brachytherapy.- Retinoblastoma: Intravenous Chemotherapy.- Intra-ophthalmic Artery Chemotherapy for Retinoblastoma.- Retinoblastoma: Intravitreal chemotherapy.- Retinoblastoma: External beam radiation.- Retinoblastoma: Enucleation.- Retinoblastoma: Evolving Therapies.- Histopathologic Features and Prognostic Factors.- Orbital Retinoblastoma: Diagnosis and Management.- Retinoblastoma: Metastatic Disease.- Non ocular tumors and other long term complications.- Trilateral Retinoblastoma.- Screening Children at Risk for Retinoblastoma.- Children's Oncology Group (COG) Trials for Retinoblastoma.- Social Aspects, Advocacy and Organizations.


Erscheinungsdatum
Zusatzinfo XIV, 303 p. 111 illus., 99 illus. in color.
Verlagsort Cham
Sprache englisch
Original-Titel Clinical Ophthalmic Oncology
Maße 178 x 254 mm
Gewicht 816 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Augenheilkunde
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte Cancer Staging • clinical ophthalmic oncology • complications • immunology • reinoblastoma • targeted therapy • Tumor Associated Diseases
ISBN-10 3-030-11122-9 / 3030111229
ISBN-13 978-3-030-11122-9 / 9783030111229
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich